Next Article in Journal
Glutamine Supplementation as an Anticancer Strategy: A Potential Therapeutic Alternative to the Convention
Previous Article in Journal
Comparing Molnupiravir to Nirmatrelvir/Ritonavir (Paxlovid) in the Treatment of Mild-to-Moderate COVID-19 in Immunocompromised Cancer Patients
 
 
Review

Article Versions Notes

Cancers 2024, 16(5), 1056; https://doi.org/10.3390/cancers16051056
Action Date Notes Link
article xml file uploaded 5 March 2024 10:32 CET Original file -
article xml uploaded. 5 March 2024 10:32 CET Update https://www.mdpi.com/2072-6694/16/5/1056/xml
article pdf uploaded. 5 March 2024 10:32 CET Version of Record https://www.mdpi.com/2072-6694/16/5/1056/pdf
article html file updated 5 March 2024 10:34 CET Original file https://www.mdpi.com/2072-6694/16/5/1056/html
Back to TopTop